## A T ~N O squamous cell carcinoma of the true vocal cord is rarely a controversial lesion. In fact, this is a lesion about which surgeons and radiotherapy therapists usually agree, and radiotherapy is usually the treatment of choice. However, when a lesion fails conventional treatment not everyo
Controversies. T1 squamous cell carcinoma of the true vocal cord
β Scribed by Snyderman, Nancy L. ;Marks, Richard ;Clark, Keith ;Wetmore, Stephen J.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1988
- Weight
- 209 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0148-6403
No coin nor oath required. For personal study only.
β¦ Synopsis
T h e diversified armamentarium for treating T1 carcinomas of the glottis has led most head and neck surgeons to expect high cure rates. Yet controversy persists. Concern centers around which modality is most straightforward and which offers the best posttreatment voice. With new "conservative" forms of treatment, is the overall approach most "radical"?
A 52-year-old salesman presented with a 4month history of hoarseness. He smoked 1% packs of cigarettes a day and drank 1 or 2 beers each day. He denied dysphagia, odynophagia, or weight loss. Direct laryngoscopy revealed a lesion of the right true vocal cord. The anterior commissure appeared free of disease and both vocal cords are mobile. A biopsy confirmed a TlNOMO moderately well-differentiated squamous cell carcinoma (Figure 1). The remainder Readers are invited to submit particularly difficult cases for consideration to
π SIMILAR VOLUMES
## Abstract ## Purpose To report longβterm rates of tumor control after radiotherapy (RT) for carcinoma in situ (CIS) of the true vocal cords (TVC). A comprehensive literature review was performed, and outcomes with other modalities of treatment for CIS of the TVC were compared. ## Materials and
The current treatment paradigm for patients with advanced laryngeal squamous cell carcinoma continues to evolve. The authors assembled a panel of experts from the fields of medical oncology, radiation oncology, and surgery to discuss treatment options and to defend their positions.
This is an analysis of 304 patients with invasive, previously untreated T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy between October 1964 and December 1984. All patients had a minimum 2-year follow-up and 82% had at least 5 years of follow-up. Patients were excluded
## Abstract Loss of distal 9p is a common genetic alteration in squamous cell carcinoma of the head and neck. A vocal cord lesion incorporating a carcinomaβinβsitu and a focus of invasive carcinoma revealed loss of the Y chromosome and a 9p22 rearrangement with loss of 9p22βpter. Loss of 9p22βpter
## Abstract __Background.__ To assess whether survival or local control of early squamous cell carcinoma of the tonsil has been compromised by a moderateβdose approach. __Methods.__ Between 1970 and 1989, 185 patients with SCCa of the tonsil were seen at our institution. Fiftyβthree patients with